SQSTM1 and cancer: Despite these two possible mechanisms of downregulation of the p62‐Keap1‐Nrf2 pathway, the fact that p62 is a target gene of Nrf2 3 (Fig. 1A) opens the possibility for a positive feedback loop that is exploited in many forms of cancer.